Journal profile · Medicine-Endocrinology, Diabetes and Metabolism
BMJ Open Diabetes Research & Care
ISSN 2052-4897 · BMJ Publishing Group · United Kingdom
BMJ Open Diabetes Research & Care: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.33; fully open access; APC charged, amount not published; median 143 days to acceptance (103 articles, last 24 months); acceptance rate 8% (journal website); 89 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
BMJ Open Diabetes Research & Care is published by BMJ Publishing Group and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Management and Research and Diabetes Treatment and Management, together about 37.3% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Acceptance Rate:8%Time from acceptance to publication:26 days*Impact Factor (JCR):4.4Citescore:82025 Total content views:440,6582025 Total Altmetric mentions:523More journal metricsHow we get these metrics*median number of days Aims & scope Editorial board Ownership Journal information Journal Statistics 2025 Advertising Affiliations
From the journal's Aims & Scope
Research area (LetPub): Medicine-Endocrinology, Diabetes and Metabolism
Editor-in-chief Mandeep BajajPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine15.1%
- Diabetes Management and ResearchMedicine11.2%
- Diabetes Treatment and ManagementMedicine11%
- Diabetes Management and EducationMedicine9.6%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology6.9%
- Hyperglycemia and glycemic control in critically ill and hospitalized patientsMedicine5.4%
- Pancreatic function and diabetesMedicine4.7%
- Gestational Diabetes Research and ManagementMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.33LetPub ·
- Impact factor (publisher) 2025
- 4.4Publisher website ·
- CiteScore 2026-06
- 8LetPub ·
- CiteScore (publisher)
- 8Publisher website ·
- SJR 2026-06
- 1.65LetPub ·
- SNIP 2026-06
- 1.48LetPub ·
- h-index
- 87OpenAlex ·
- i10-index
- 1,066OpenAlex ·
- 2-year mean citedness
- 4.86OpenAlex ·
- Self-citation rate
- 2.3%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 81LetPub ·
Articles by year OpenAlex count · 1,584 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 60 | 60 | 19 |
| 2025 | 89 | 89 | 294 |
| 2024 | 118 | 118 | 984 |
| 2023 | 103 | 103 | 1,668 |
| 2022 | 143 | 143 | 2,884 |
| 2021 | 230 | 230 | 5,686 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
143 daysMedian, submission to acceptance · P25–P75 93 days – 172 days
- Acceptance to online
- median 24 days (103 articles)
- Submission to online
- median 165 days
- Sample
- 103 articles with submission and acceptance dates (173 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 18 weeksLetPub ·
- Acceptance rate (publisher)
- 8%Publisher website ·
- Acceptance to publication
- 26 daysPublisher website ·
- Submission to publication (journal-reported)
- about 23 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | GBP 3,580 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 3,000 | — | — | |
| LetPub | USD 2,972 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- BMJ Publishing Group
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2052-4897
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about BMJ Open Diabetes Research & Care
What CAS zone is BMJ Open Diabetes Research & Care in?
In the 2025 upgraded edition of the CAS Journal Ranking, BMJ Open Diabetes Research & Care is in Zone 2 of Medicine, and in Zone 2 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of BMJ Open Diabetes Research & Care?
The latest impact factor listed by LetPub is 4.33; CiteScore 8, h-index 87.
How long does peer review take at BMJ Open Diabetes Research & Care?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 143 days (interquartile range 93–172 days); authors report an average review time of about 18 weeks; the journal's website gives an acceptance rate of 8%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index BMJ Open Diabetes Research & Care?
According to LetPub and DOAJ records, BMJ Open Diabetes Research & Care is indexed in SCIE, Scopus and DOAJ.
Is BMJ Open Diabetes Research & Care open access, and what is the APC?
BMJ Open Diabetes Research & Care is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .